EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Optimising Therapeutic Target Attainment in Vancomycin Therapy for Patients Requiring Intermittent Haemodialysis

Danny Tsai, María Patricia Hernández-Mitre, Amy Legg, Jacqueline Martin, Cherian Sajiv, Sachin Kodgire, William Naughton, Sonja Janson, Jaquelyne T Hughes iD, Xin Liu, Jason A Roberts

Nephrology · 2026-07 · 31 (7)

DOI: 10.1111/nep.70239 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology, online erschienen am 29.06.2026. Verfasst von Danny Tsai und 10 weiteren Autor:innen. Beteiligte Einrichtung: Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Darwin, Northern Territory, Australia. Hauptthemen laut MEDLINE: Vancomycin, Anti-Bacterial Agents, Renal Dialysis. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The Hospital Research Foundation, Australian National Health and Medical Research Council, Hospital Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To describe the pharmacokinetics of vancomycin in patients requiring intermittent haemodialysis (iHD) and provide guidance for optimised dosing for a three‐times‐weekly post‐iHD regimen.

Methods

A population pharmacokinetic study using retrospectively collected data was conducted in a remote Australian dialysis centre. Adult patients receiving post‐iHD vancomycin therapy between 1st January 2017 and 31st July 2023 were screened. Inclusion criteria: ≥ 3 months of iHD, prescribed vancomycin, and recorded ≥ 1 vancomycin concentration. Pharmacokinetic analysis was performed using Monolix. The probability of pharmacokinetic/pharmacodynamic target attainment (PTA) for pre‐iHD trough concentrations of 15–20 mg/L was simulated for various loading and maintenance doses.

Results

A total of 302 vancomycin concentrations were available from 80 courses (58 patients, 45 were female) with a median age of 52 (IQR 45–61) years and weight of 75 (66.5–85.5) kg. A one‐compartment model adequately described the data. Actual body weight was the only covariate retained in the final model. The estimated vancomycin clearance during non‐iHD periods, during iHD periods, and volume of distribution were 0.54 L/h, 4.84 L/h, and 87.02 L, respectively. The simulations supported weight‐based loading doses. The time to the next iHD session also significantly influenced the PTA of loading doses. Subjects with higher weight required lower weight‐based doses, and vice versa. The PTA of maintenance doses was associated with the pre‐iHD trough concentrations and the dosing intervals. Weight had a limited impact on the PTA of maintenance doses.

Conclusion

A comprehensive vancomycin dosing nomogram was suggested for patients requiring iHD. Validation in future prospective studies is recommended.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VancomycinAnti-Bacterial AgentsRenal DialysisHumansFemaleMiddle AgedRetrospective StudiesMale

Stichwörter der Autor:innen

dosingintermittent haemodialysispharmacokineticsvancomycin

Substanzen

VancomycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Darwin, Northern Territory, Australia.
  • Pharmacy Department, Alice Springs Hospital, Alice Springs, Northern Territory, Australia.
  • UQ Centre for Clinical Research, The University of Queensland, Brisbane, Queensland, Australia.
  • Department of Nephrology, Alice Springs Hospital, Alice Springs, Northern Territory, Australia.
  • Department of Medicine, Alice Springs Hospital, Alice Springs, Northern Territory, Australia.
  • Department of Infectious Diseases, Royal Darwin Hospital, Darwin, Northern Territory, Australia.

ORCID-Profile: Jaquelyne T Hughes

Förderung

  • The Hospital Research Foundation
  • Australian National Health and Medical Research Council
  • Hospital Research Foundation

Zitieren

APA

Tsai, D., Hernández-Mitre, M. P., Legg, A., Martin, J., Sajiv, C., Kodgire, S., Naughton, W., Janson, S., Hughes, J. T., Liu, X., & Roberts, J. A. (2026). Optimising Therapeutic Target Attainment in Vancomycin Therapy for Patients Requiring Intermittent Haemodialysis. Nephrology, 31(7). https://doi.org/10.1111/nep.70239

Vancouver

Tsai D, Hernández-Mitre MP, Legg A, Martin J, Sajiv C, Kodgire S, et al. Optimising Therapeutic Target Attainment in Vancomycin Therapy for Patients Requiring Intermittent Haemodialysis. Nephrology. 2026;31(7). doi:10.1111/nep.70239

BibTeX
@article{Tsai2026,
  author = {Tsai, Danny and Hernández-Mitre, María Patricia and Legg, Amy and Martin, Jacqueline and Sajiv, Cherian and Kodgire, Sachin and Naughton, William and Janson, Sonja and Hughes, Jaquelyne T and Liu, Xin and Roberts, Jason A},
  title = {Optimising Therapeutic Target Attainment in Vancomycin Therapy for Patients Requiring Intermittent Haemodialysis},
  journal = {Nephrology},
  year = {2026},
  volume = {31},
  number = {7},
  doi = {10.1111/nep.70239}
}
Kostenlos starten →